Science Vs
Introducing The Journal: Trillion Dollar Shot
Jun 11, 2024
The podcast explores the business story behind blockbuster drugs like Ozempic for weight loss. It focuses on the Novo Nordisk scientist who invented the compound paving the way for Ozempic. It discusses the development, impact, and challenges faced in the pharmaceutical market and the affordability issues related to weight loss medications.
41:06
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Development of GLP-1 drugs for weight loss originated from Novo Nordisk's innovation.
- Affordability of GLP-1 medications poses a significant barrier for individuals seeking weight loss treatment.
Deep dives
Development of GLP-1 Drugs for Weight Loss
The podcast episode delves into the origin story of GLP-1 drugs, specifically focusing on Novo Nordisk's development of Ozempic. Initially designed to treat diabetes, these drugs were found to aid in weight loss. The journey of creating a long-lasting GLP-1 compound that led to the development of liraglutide, later known as Victoza, is highlighted. Despite initial setbacks, the perseverance and innovation of the team led to the approval of these drugs, paving the way for significant weight loss outcomes.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
